T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CADE
1926
DELISTED
Cadence Bancorporation
CADE
| $1.26M | ﹤0.01% |
57,476
-135,955
| -70% | -$2.77M |
|
|
AIMC
1927
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.26M | ﹤0.01% |
22,716
-1,516
| -6% | -$90.4K |
|
1928
Sonos
SONO
$1.86B
| $1.26M | ﹤0.01% |
38,810
-63
| -0.2% | -$2.27K |
|
1929
Fulcrum Therapeutics
FULC
$283M
| $1.25M | ﹤0.01% |
+44,400
| New | +$841K |
|
1930
Four Corners Property Trust
FCPT
$2.74B
| $1.25M | ﹤0.01% |
46,418
+200
| +0.4% | +$5.6K |
|
1931
CareTrust REIT
CTRE
$9.18B
| $1.25M | ﹤0.01% |
61,257
-1,515
| -2% | -$34.2K |
|
1932
Dycom Industries
DY
$12.3B
| $1.25M | ﹤0.01% |
17,472
-612
| -3% | -$43.3K |
|
|
CSGS
1933
DELISTED
CSG Systems International
CSGS
| $1.24M | ﹤0.01% |
25,804
-2,229
| -8% | -$104K |
|
1934
Suncor Energy
SU
$76.5B
| $1.24M | ﹤0.01% |
60,010
+90
| +0.2% | +$1.8K |
|
1935
Amkor Technology
AMKR
$14.3B
| $1.24M | ﹤0.01% |
49,801
-18,876
| -27% | -$482K |
|
|
AAN
1936
DELISTED
The Aaron's Company Inc
AAN
| $1.24M | ﹤0.01% |
45,147
-1,281,150
| -97% | -$36M |
|
|
SI
1937
DELISTED
Silvergate Capital Corporation
SI
| $1.24M | ﹤0.01% |
10,752
+1,799
| +20% | +$193K |
|
1938
HF Sinclair
DINO
$15.6B
| $1.24M | ﹤0.01% |
37,324
-828
| -2% | -$25.2K |
|
1939
Patterson-UTI
PTEN
$4.16B
| $1.23M | ﹤0.01% |
136,961
+27,600
| +25% | +$223K |
|
|
UCTT
1940
Ultra Clean Holdings
UCTT
$4.21B
| $1.23M | ﹤0.01% |
28,932
-2,000
| -6% | -$94.3K |
|
1941
First Financial Bancorp
FFBC
$3.6B
| $1.23M | ﹤0.01% |
52,528
-4,457
| -8% | -$102K |
|
|
HAPN
1942
Happen Inc
HAPN
$2.27B
| $1.23M | ﹤0.01% |
43,510
-7,947
| -15% | -$197K |
|
|
CIO
1943
DELISTED
City Office REIT
CIO
| $1.23M | ﹤0.01% |
68,587
-193
| -0.3% | -$2.81K |
|
1944
AngioDynamics
ANGO
$647M
| $1.22M | ﹤0.01% |
47,041
+135
| +0.3% | +$3.61K |
|
1945
Ares Capital
ARCC
$14.5B
| $1.22M | ﹤0.01% |
60,000
| – | – |
|
1946
Edgewell Personal Care
EPC
$1.32B
| $1.22M | ﹤0.01% |
33,613
+1,059
| +3% | +$43.5K |
|
1947
Sterling Infrastructure
STRL
$16.8B
| $1.22M | ﹤0.01% |
53,760
+1,250
| +2% | +$27.9K |
|
1948
Ligand Pharmaceuticals
LGND
$5.76B
| $1.22M | ﹤0.01% |
14,020
-994
| -7% | -$76.9K |
|
1949
International Bancshares
IBOC
$4.52B
| $1.22M | ﹤0.01% |
29,238
-38
| -0.1% | -$1.55K |
|
1950
NetEase
NTES
$78.5B
| $1.21M | ﹤0.01% |
14,220
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.